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Abstract: Flow chemistry has been successfully integrated
into the synthesis of a series of cyclooligomeric depsipepti-
des of three different ring sizes including the natural prod-
ucts beauvericin (1a), bassianolide (2b) and enniatin C (1b).
A reliable flow chemistry protocol was established for the
coupling and macrocyclisation to form challenging N-methy-
lated amides. This flexible approach has allowed the rapid
synthesis of both natural and unnatural depsipeptides in
high yields, enabling further exploration of their promising
biological activity.
Introduction
Beauvericin (1a), enniatin C (1b) and bassianolide (2b ;
Figure 1) are nonribosomal cyclooligomeric depsipeptides
(CODs), with structures derived from repeated oligopeptidol
monomer units consisting of d-2-hydroxyisovalerate (d-Hiv)
and N-methylated amino acids joined head-to-tail in a macrocy-
cle. Fungal CODs such as these are of particular interest be-
cause they exhibit a wide variety of biological activities, includ-
ing as antibiotics or insecticides,[1] and some are known for
their ability to bind ions.[2]
The structure of beauvericin (1a), which consists of three re-
peated d-Hiv-l-N-Me-Phe units, was first reported in 1969 from
the fungus Beauveria bassiana. It exhibited toxicity towards
brine shrimp and moderate inhibitory activity towards Gram-
positive bacteria, fungi and mosquito larvae.[3] Beauvericin has
subsequently been found to be produced by a range of Fusari-
um species[4] and is a known mycotoxin, occurring naturally on
corn, corn-based foods and feeds which are infected by these
fungi. Due to this, methods for the detection of 1a for food
safety and its toxicity to normal human cells have been investi-
gated.[5]
Bassianolide (2b) was isolated in 1977 from B. bassiana and
Verticillium lecanii—fungi isolated from silkworm pupae car-
casses—and was shown to kill silkworm larvae by oral adminis-
tration at dosage levels of more than 8 ppm, whereas beauver-
icin (1a) had no effect by oral administration even at a dose of
1000 ppm. The structure was determined to be a COD consist-
ing of four repeated d-Hiv-l-N-Me-Leu units.[6] A wide range of
additional biological activities for both 1a and 2b have been
reported since their initial isolation.[7]
Enniatin C (1b), which consists of three repeated d-Hiv-l-N-
Me-Leu units, was first reported in 1968 when it was synthes-
ised as an unnatural member of the enniatin family.[8] It was
also isolated by precursor-directed biosynthesis using Verticilli-
um hemipterigenum strain BCC 1449 in 2003.[9] Enniatin C was
subsequently found to be naturally produced by V. hemipteri-
genum BCC 1449 in 2004, albeit in very small amounts.[10]
Figure 1. COD natural products beauvericin (1a), enniatin C (1b), enniatin B
(1c) and bassianolide (2b).
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The bioactivity of these compounds, particularly the fact
that there are marked differences between the activities of dif-
ferent CODs, is of significant interest. This means that having
robust synthetic access to these natural products, as well as
the ability to make unnatural analogues, would enable further
evaluation to potentially enhance desirable biological activity.
Although directed biosynthesis has been used to successfully
synthesise small libraries of beauvericin[11] and enniatin[12] ana-
logues, the structures obtainable by this method are limited
by the substrate scope of the synthase used.
Syntheses of the three natural product target molecules of
this study have been previously reported, in all cases the pep-
tide couplings were carried out via acid chloride intermediates.
Ovchinnikov et al. reported a synthesis of enniatin C (1b) in
1968[8] and beauvericin (1a) in 1971.[13] Both syntheses used
thionyl chloride as the chlorinating reagent, with 1a afforded
in an overall yield of 9%.[13] The total synthesis of bassianolide
(2b) was reported soon after its isolation by Suzuki et al.[14]
This synthesis used PCl5 for the amide coupling steps and af-
forded 2b in overall 9.5% yield, with the same route being ap-
plied to the synthesis of 1b to afford this molecule in 2.8%
overall yield.[14b] The practicality of acid chloride intermediates
for peptide couplings has historically been constrained by their
inherent over-activation, which makes them prone to side re-
actions, especially with carboxybenzyl (Cbz) or tert-butyloxycar-
bonyl (Boc) protection strategies, which combined with the
unpleasant nature of the reagents needed for their synthesis
has limited their application.[15]
Previous work in our group has established a solution phase
synthesis for the 18-membered COD enniatin B (1c), which is
the cyclic trimer of d-Hiv-l-N-Me-Val units. This work used
Ghosez reagent (1-chloro-N,N,2-trimethyl-1-propenylamine),[16]
which allowed the formation of the required acid chloride in-
termediates under near neutral conditions and afforded 1c in
a respectable overall yield of 15%.[17] The work herein reports
the extension of this work to the synthesis of 12-, 18- and 24-
membered CODs based on d-Hiv-l-N-Me-Phe and d-Hiv-l-N-
Me-Leu monomer units, which includes the natural products
beauvericin (1a), enniatin C (1b) and bassianolide (2b), both
in batch and with the integration of flow chemistry methods.
Although chemical synthesis is generally favoured to access
peptides due to its inherent flexibility,[18] existing methods are
often highly inefficient, suffering from poor atom economy,
challenging purifications and difficulties in scale-up process-
es.[19] The operational simplicity of solid phase peptide synthe-
sis[20] (SPPS) has led to it becoming widely regarded as the
method of choice for peptide synthesis,[21] however one of the
major limitations of SPPS is its fundamental lack of atom econ-
omy. SPPS typically employs a four- to tenfold excess of build-
ing blocks to force reactions to completion, which is significant
with costly monomer units, such as d-Hiv and the related hy-
droxyester components needed to synthesise depsipeptides.[22]
Solid phase depsipeptide synthesis is also known to be prob-
lematic, with approaches often relying on using depsipeptide
building blocks rather than forming the depsipeptide linkages
on resin.[23]
After our group’s previous work on peptide couplings in
flow,[24] cyclooligomeric depsipeptides were chosen as the tar-
gets for the current work as they exhibit highly desirable bio-
logical activity,[1] contain challenging N-methylated amide
bonds,[25] and could be built-up iteratively as they consist of re-
peated dipeptidol monomer units. The accurate control of re-
action parameters possible, potential for inline monitoring/au-
tomation and simplicity of scale-up offered by flow chemistry
give it exciting potential to solve the inherent problems with
acid chloride mediated peptide synthesis,[15] while in addition
considerably reducing the labour involved in the synthesis
through iterative protocols.
Results and Discussion
Batch synthesis of CODs
Initially, attention focused on the batch synthesis of CODs with
two to four dipeptidol units with N-Me-Phe and N-Me-Leu as
the amino acid component, using the methods established in
our group’s previous synthesis of the related COD enniatin B
(1c).[17] The synthesis began from d-a-hydroxyisovaleric acid
(3), which is commercially available or could be accessed
through methodology previously developed in Cambridge.[26]
The acid functionality was protected to give benzyl ester 4
which was coupled with either Boc-N-methyl-phenylalanine
(5a) or Boc-N-methyl-leucine (5b) using 1-ethyl-3-(3-dimethyl-
aminopropyl)carbodiimide hydrochloride (EDCI) and 4-dimeth-
ylaminopyridine (4-DMAP) to afford the dipeptidol building
blocks for the two COD series, 6a and 6b, respectively, in high
yields (Scheme 1).
Iterative deprotection and coupling steps were then used to
assemble linear COD precursors of two (8), three (10) and four
(11) dipeptidol units (Scheme 2). The amines were Boc depro-
tected using anhydrous hydrochloric acid (HCl) in dioxane and
the benzyl protection removed from the acids by hydrogena-
tion with palladium on charcoal, with both deprotected prod-
ucts able to be used directly in the coupling without further
purification. The deprotected coupling partners were coupled
via the acid chloride intermediate using Ghosez reagent[16] in
Scheme 1. Synthesis of depsipeptide monomers. a) BnBr, Cs2CO3, DMF, 0 8C–RT, 15 h, 80%; b) 4-DMAP, EDCI, CH2Cl2, 0 8C–RT, 24 h, 6a=92%, 6b=92%.
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dichloromethane in the presence of diisopropylethylamine.
Ghosez reagent was chosen as the coupling reagent as it is
fully soluble and is therefore suitable for use in flow, where
precipitates can be problematic. This provided access to all six
target linear precursors by one (8) or two coupling steps (10
and 11) in yields (for the combined deprotections and cou-
pling) ranging from 57–78%. Attention then turned to the
often challenging macrocyclisations. Pleasingly it was found
that after the global deprotection of the linear precursors,
using the established conditions, Ghosez reagent could be suc-
cessfully employed to macrocyclise intermediates of all three
sizes to form 12, 18 and 24 atom rings. Beauvericin (1a), bas-
sianolide (2b) and enniatin C (1b) were successfully synthes-
ised in overall yields of 26, 24 and 15%, respectively
(Scheme 2). These overall yields are significant improvements
upon those achieved previously.[13,14] While the synthesis of 12-
membered ring macrocycles was found to be possible, it was
seen that the conditions afforded modest yields of the desired
ring size (17% for 9a and 19% for 9b), accompanied with
higher yields of the product resulting from an intermolecular
dimerization occurring prior to macrocylisation (41% of 2a
and 45% of bassianolide 2b). While this represents a shortened
Scheme 2. Batch synthesis of cyclooligomeric depsipeptides. a) 10% Pd/C, H2, THF, RT, a : 2.5 h/b : 3 h; b) anhydrous HCl, dioxane, RT, 3 h; c) acid, Ghosez re-
agent 7, CH2Cl2, 0 8C, a : 20 min/b : 25 min then iPr2EtN, CH2Cl2, amine, 0 8C–RT, a : 17 h/b : 22 h, 8a=68%, 8b=64%; d) a : 10% Pd/C, H2, THF, RT, 6 h, or b : H-
CubeÒ Pro, 10% Pd/C CatCartÒ, CH2Cl2, 1 mLmin
¢1, 60 8C, 6 bar; e) anhydrous HCl, dioxane, RT, a : 6 h/b : 5 h 25 min; f) Ghosez reagent 7, CH2Cl2, 0 8C, a :
20 min/b : 15 min then iPr2EtN, CH2Cl2, 0 8C–RT, a : 21 h/b : 20 h, 9a=17% and 2a=41%, 9b=19% and 2b=45%; g) 10% Pd/C, H2, THF, RT, a : 2 h 30 min/b :
3 h 15 min; h) anhydrous HCl, dioxane, RT, 6 h; i) acid, Ghosez reagent 7, CH2Cl2, 0 8C, 20 min then iPr2EtN, CH2Cl2, amine, 0 8C–RT, 18 h, 10a=75%,
10b=78%; j) a : 10% Pd/C, H2, THF, RT, 6 h, or b : H-CubeÒ Pro, 10% Pd/C CatCartÒ, CH2Cl2, 1 mLmin
¢1, 60 8C, 6 bar; k) anhydrous HCl, dioxane, RT, 6 h;
l) Ghosez reagent 7, CH2Cl2, 0 8C, 30 min then iPr2EtN, CH2Cl2, 0 8C–RT, a : 18 h 30 min/b : 18 h, 1a=70%, 1b=42%; m) 10% Pd/C, H2, THF, RT, a : 6 h/b : 5 h
30 min; n) anhydrous HCl, dioxane, RT, a : 6 h/b : 5 h; o) acid, Ghosez reagent 7, CH2Cl2, 0 8C, a : 20 min/b : 25 min then iPr2EtN, CH2Cl2, amine, 0 8C–RT, a : 20 h
30 min/b : 16 h, 11a=57%, 11b=75%; p) a : H-CubeÒ Pro, 10% Pd/C CatCartÒ, MeOH/CH2Cl2, 1 mLmin
¢1, 60 8C, 6 bar or b : 10% Pd/C, H2, THF, RT, 6 h; q) an-
hydrous HCl, dioxane, RT, a : 6 h 50 min/b : 5 h; r) Ghosez reagent 7, CH2Cl2, 0 8C, a : 20 min/b : 30 min then iPr2EtN, CH2Cl2, 0 8C–RT, a : 19 h 30 min/b : 18 h,
2a=30%, 2b=67%.
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approach for the synthesis of bassianolide (2b) and 2a, this
was less desirable if access to the 12-membered rings was the
aim.
Room temperature 1H and 13C NMR spectroscopy showed
that the 12- (9a and 9b) and 18- (1a and 1b) membered
CODs existed in one symmetrical conformation in chloroform.
In comparison, the 24-membered CODs (2a and 2b) existed as
a mixture of conformers in chloroform, dimethylsulfoxide and
toluene at room temperature. Heating to 363 K in toluene re-
sulted in the 1H and 13C NMR spectra coalescing to a single
spectrum where all the dipeptidol units were in the same envi-
ronment (Figure 2).
Flow integrated synthesis
With the batch synthesis of the six target CODs accomplished,
attention turned to establishing whether it was possible to im-
prove these syntheses by the intelligent incorporation of flow
technology. Work focused on the iterative peptide couplings,
since the batch methods to produce dipeptidol starting mate-
rials 6a and 6b were high yielding and easily scalable so fur-
ther optimisation was not considered to be necessary.
First it was desirable to establish whether the deprotection
steps could be carried out in flow to allow potential telescop-
ing of the steps. Benzyl protection had been selected for the
carboxy terminus as this allows removal of the ester by simple
hydrogenation. Flow hydrogenation has precedent using an H-
CubeÒ flow hydrogenator.[27] Using dipeptidol 6b as a test sub-
strate, it was seen that hydrogenation in dichloromethane
using a 10% palladium on carbon CatCartÒ afforded acid 12b
in good yield (Scheme 3). As the solvent was routinely re-
moved from the reaction mixture before being taken up in an
exact volume of solvent for the next step, in some cases meth-
anol was used as solvent as it was less prone to evaporation
than dichloromethane.
Attention next focused on the Boc deprotection in flow
(Table 1), with which we have experience both using heteroge-
neous (catch-and-release) and homogenous methods.[28] As
a starting point a stream of the dipeptidol 6b in dichlorome-
thane was combined with a stream of trifluoroacetic acid (TFA)
and the solvent was removed from the outflow in vacuo which
resulted in only 11% conversion to 13b. Increasing the
amount of TFA and the reaction time led to improved conver-
sion (88%); when anhydrous HCl in dioxane (17 equivalents)
Figure 2. Effect of solvent and temperature on 1H NMR of bassianolide (2b).
Scheme 3. Test flow deprotection of 6b using standard conditions.
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was used as the acid it was found that conversion decreased
to 18%. Returning to TFA as the acid, increasing both the flow
rate and coil length, overall decreasing the reaction time to
24 min, improved the conversion to 94%. Decreasing the reac-
tion time further to 10 min gave a slight reduction in conver-
sion to 90%, but it was found that raising the reaction temper-
ature to 35 8C could compensate for this (93%). Further in-
crease of the temperature to 40 8C afforded 97% conversion.
Increasing the reaction time at this temperature to 20, 30 and
40 min only resulted in a slight improvement in conversion to
98%, and increasing the amount of TFA to 40 equivalents did
not improve the conversion further.
Although this work established that the flow deprotection
of the secondary amine was possible it was considered that
the batch Boc deprotection was operationally simpler and that
flow offered no significant benefit. Therefore, it was decided to
continue to use the established batch process for this work.
Although the batch conditions had provided an idea of an
appropriate starting point for optimisation of the peptide cou-
pling steps, it was deemed prudent to first optimise the cou-
pling step using a model peptide coupling rather than wasting
the synthetically derived dipeptidol units. The coupling of Boc-
leucine (14) with phenylalanine methyl ester·HCl (15) was
chosen as a test system for this reaction as the coupling part-
ners were readily available, but this reaction had been found
to be challenging using acid chloride methods, with a yield of
only 14% resulting when the batch coupling protocol from
the depsipeptide synthesis was applied to these coupling part-
ners (Table 2, entry 1). It has been reported that Boc-protected
amino acids are not compatible with acid-chloride-mediated
peptide couplings due to their tendency to self-cyclise to form
reactive N-carboxyanhydrides[15] which could be contributing
to this low yield.
Previous work in our laboratories[29] has shown that the
stacking of reactor coils on a cryo-cooling device can allow re-
agent streams to be pre-cooled, with excellent results. It was
envisaged that this would allow the reaction of a pre-cooled
solution of acid coupling partner with a pre-cooled solution of
Ghosez reagent to allow highly controlled generation of the re-
quired acid chlorides at low temperature, which could immedi-
ately be treated with a pre-cooled solution of the amine cou-
pling partner and base to affect coupling with 1:1 stoichiome-
try. The precise control of stoichiometry and temperature this
process affords would prevent exotherms and minimise the
possible side reactions of the acid chloride intermediate. It was
a specific aim of the project to avoid conditions requiring an
excess of either coupling partner, due to the ultimate aim of
coupling more complex, and therefore expensive, coupling
partners. Once the third stream had been added, the coupling
reaction could be allowed to proceed at room temperature,
before the output is collected in a quenching solution and
worked up.
Reactions were optimised (Table 2) using plug flow, with
Sudan Red dye first being used to determine the necessary in-
jection times so that the streams met, in a similar fashion to
that used previously.[29a] The initial set-up used a single equiva-
Table 1. Optimisation of the flow Boc deprotection.
Entry Acid Equiv Solvent Flow rate per
pump [mLmin¢1]
Conc.
[m]
Vol.
[mL]
Reaction
time [min]
T [8C] Conv.
[%][a]
1 TFA 1 CH2Cl2 0.100 0.04 0 1 RT 11
2 TFA 2 CH2Cl2 0.500 0.10 10 10 RT 19
3 TFA 20 CH2Cl2 0.100 0.04 0 1 RT 43
4 TFA 20 CH2Cl2 0.033 0.10 2 30 RT 88
5 HCl 17 1,4-dioxane 0.033 0.10 2 30 RT 18
6 TFA 20 CH2Cl2 0.333 0.10 16 24 RT 94
7 TFA 20 CH2Cl2 0.500 0.10 10 10 RT 90
8 TFA 20 CH2Cl2 0.500 0.10 10 10 35 93
9 TFA 20 CH2Cl2 0.500 0.10 10 10 40 97
10 TFA 20 CH2Cl2 0.250 0.10 10 20 40 98
11 TFA 20 CH2Cl2 0.167 0.10 10 30 40 98
12 TFA 20 CH2Cl2 0.125 0.10 10 40 40 98
13 TFA 40 CH2Cl2 0.125 0.10 10 40 40 98
[a] Conversion was determined using 1H NMR spectroscopy of crude reaction mixtures.
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lent of Ghosez reagent and flow rates of 0.50 mLmin¢1 for
each pump, resulting in a reaction time for the formation of
the acid chloride at 0 8C of 3 min and the coupling was carried
out at room temperature with a reaction time of 6 min 40 s, re-
sulting in a 3% isolated yield of the desired product. Doubling
the equivalents of Ghosez reagent increased the yield to 19%,
an improvement over the yield achieved for this coupling in
batch. As there were concerns over whether the Ghosez re-
agent was decomposing before it reached the cooled reaction
coils, next the solvent reservoirs were cooled to 0 8C. This was
seen to have negligible effect on the yield of the reaction, so
routinely solvents were not cooled. Both decreasing and in-
creasing the flow rate resulted in a decrease in the yield, whilst
increasing the coupling time by increasing the volume of coil
E had no appreciable effect on yield, indicating that the acid
chloride formation time rather than the coupling reaction time
was limiting yield. This was supported by the fact that when
the volume of coil C was increased to give a 5 min acid chlo-
ride formation time at the 1 mLmin¢1 flow rate, the yield for
this reaction increased to 19%, even with the coupling reac-
tion time being only 6 min 40 s. Attention next focused on the
quenching of the reaction mixture. It was found that if the
output stream was quenched with stirring aqueous HCl at 0 8C
rather than at room temperature that there was a significant
increase in yield to 33%. Using saturated ammonium chloride
or water at 0 8C resulted in slightly reduced yields. It was
found that diluting the coupling partners to 0.02 or 0.01m sig-
nificantly improved the yield of the reaction to 44 and 46%, re-
spectively.
With the reaction significantly optimised from the original
conditions, it was then desirable[30] to determine whether the
observed increase in yield was due to “flow effects” or if it was
simply that the ease of screening conditions in flow had al-
lowed us to better optimise this reaction. In order to do this,
batch conditions were employed which mimicked the opti-
mised flow conditions as closely as possible and it was seen
that the batch yield was identical to when that coupling was
carried out in flow, although it should be noted that the flow
process was considerably simpler operationally. To investigate
whether scale was a factor for this reaction, the reaction was
carried out both in batch and in flow on 0.6 mmol scale. When
this reaction was carried out in batch the increased volume re-
sulted in considerable complications, with addition of the two
60 mL solutions by cannula taking over 4 min each, and the
Table 2. Optimisation of reaction conditions using model coupling.
Entry Flow rate per Scale Conc. T Activation Vol. [mL] Equiv. Ghosez Reaction Workup Yield
pump [mLmin¢1] [mmol] [m] solvent time [min] A B C D E reagent time [min] [%]
1 batch 0.50 0.10 – 20 – – – – – 1 930 RT/1m HCl 14
2 0.50 0.50 0.10 RT 3 2.5 2.5 3 3 10 1 6.67 RT/1m HCl 3
3 0.50 0.50 0.10 RT 3 2.5 2.5 3 3 10 2 6.67 RT/1m HCl 19
4 0.50 0.50 0.10 0 8C 3 2.5 2.5 3 3 10 2 6.67 RT/1m HCl 18
5 0.25 0.50 0.10 RT 6 2.5 2.5 3 3 10 2 13.3 RT/1m HCl 11
6 1.00 0.50 0.10 RT 1.5 2.5 2.5 3 3 10 2 3.33 RT/1m HCl 12
7 1.00 0.50 0.10 RT 1.5 2.5 2.5 3 3 20 2 6.67 RT/1m HCl 11
8 0.50 0.50 0.10 RT 3 2.5 2.5 3 3 20 2 13.3 RT/1m HCl 18
9 1.00 0.50 0.10 RT 5 3 3 10 2.5 20 2 6.67 RT/1m HCl 19
10 1.00 0.50 0.10 RT 5 3 3 10 2.5 20 2 6.67 0 8C/1m HCl 33
11 1.00 0.50 0.10 RT 5 3 3 10 2.5 20 2 6.67 0 8C/sat. NH4Cl 31
12 1.00 0.50 0.10 RT 5 3 3 10 2.5 20 2 6.67 0 8C/H2O 28
13 1.00 0.10 0.02 RT 5 3 3 10 2.5 20 2 6.67 0 8C/1m HCl 44
14 1.00 0.05 0.01 RT 5 3 3 10 2.5 20 2 6.67 0 8C/1m HCl 46
15 batch 0.05 0.01 – 5 – – – – – 2 6.67 0 8C/1m HCl 46
16 batch 0.60 0.01 – 5 – – – – – 2 6.67 0 8C/1m HCl 23
17 1.00 0.60[a] 0.01 RT 5 3 3 10 2.5 20 2 6.67 0 8C/1m HCl 47
[a] Reaction was run continuously for 1 h after reaching steady state
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yield dropping significantly to 23%. For the flow reaction, reac-
tion mixtures of appropriate concentration were run continu-
ously for 1 h after being allowed to reach what we expect to
be steady state, based on the anticipated rapid kinetics of the
process (1.5 reactor volumes, 30 min).[30] Pleasingly, the contin-
uous flow yield was comparable to the plug flow yield (47%),
highlighting one of the key benefits of flow chemistry—its
ease of scale-up.
With conditions established for the coupling and deprotec-
tions attention turned to the application of this to the synthe-
sis of the target cyclooligomeric depsipeptides. The flow inte-
grated synthesis of the depsipeptides began with the intermo-
lecular couplings to give the necessary linear precursors for
macrocyclisation. The appropriate coupling partners were de-
protected either by flow hydrogenation to afford the acid or
by batch removal of the Boc group with anhydrous HCl in di-
oxane to afford the HCl salt of the amine. These crude prod-
ucts were then taken up in solvent and coupled using the op-
timised flow conditions.
Pleasingly, it was seen that the couplings proceeded in im-
proved yields for all linear precursors with the average yield
for these couplings increasing from 70% in batch to 80% in
flow (Table 3).
With the linear precursors in hand attention turned to the
intramolecular macrocyclisation. Both termini were deprotect-
ed as before and in order to simplify the setup, rather than in-
jecting the base as a third plug the third stream was run con-
tinuously as a 0.036m solution of diisopropylethylamine
(3.6 equivalents) in dichloromethane (Table 4). The macrocycli-
sation in flow was found to be very effective—affording all
three size rings for each dipeptidol monomer in significantly
improved yield from that achieved in batch—with the average
yield going from 41% in batch to 81% in flow. Especially nota-
ble was the improvement in the macrocyclisation of 8a and
8b to give the 12-membered cyclooligomeric depsipeptides
9a and 9b, respectively. Whereas in batch significantly more of
the product resulting from the dimerization then macrocyclisa-
tion to give 24-membered rings (2) was formed than the de-
sired 12-membered products (9), the dilution and precise tem-
perature control of the optimised flow conditions resulted in
high yields of the 12-membered rings being synthesised with-
out any detectable formation of the 24-membered rings.
Conclusions
The batch synthesis of a series of natural and unnatural CODs
was successfully accomplished in useful overall yields. The in-
formed use of flow chemistry in the synthesis of the target
CODs significantly increased the yields for the library of com-
pounds (Figure 3), with the overall yields improving by 10–
43% from the batch process. The optimised flow conditions al-
lowed inter- and intramolecular peptide couplings with consid-
Table 3. Flow synthesis of cyclooligomeric depsipeptide precursors.
Entry Product R Coupling partner 1 Coupling partner 2 Solvent Time Yield
# n1 # n2 [%]
1 8a C6H5 6a 1 6a 1 CH2Cl2 3 h 82
2 10a C6H5 6a 1 10a 2 CH2Cl2 6 h 78
3 11a C6H5 10a 2 10a 2 CH2Cl2 6 h 67
4 8b CH(CH3)2 6b 1 6b 1 MeOH 5 h 90
5 10b CH(CH3)2 6b 1 10b 2 MeOH 7 h 10 min 86
6 11b CH(CH3)2 10b 2 10b 2 MeOH 5 h 30 min 76
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erable reduction in effort for the chemist when compared to
the batch methods, additionally creating the possibility for
their future automation. The successful synthesis of the six
CODs offers the opportunity to further explore the bioactivity
of this family of compounds and this synthetic approach
would equally be suitable for the rapid synthesis of further un-
natural analogues of these molecules. Notably, the flow pep-
tide couplings were effected with rapid overall reaction times
and high yields being achieved in an atom efficient manner,
with 1:1 stoichiometry of coupling partners being used. These
results suggest that for other peptide syntheses the use of so-
lution phase couplings combined with flow methods may
prove attractive, particularly during scale-up.
Experimental Section
General methods
All reactions were carried out under argon atmosphere using
oven-dried glassware, and were monitored by TLC. Unless other-
wise stated, reagents were obtained from commercial sources and
used without further purification. Amino acids were all of the natu-
ral (l) enantiomeric form unless otherwise stated. Solvents were
freshly distilled over calcium hydride and lithium aluminium hy-
dride (tetrahydrofuran and diethyl ether) or calcium hydride (di-
chloromethane, methanol, toluene, ethyl acetate and 40–60 petro-
leum ether). Additional anhydrous solvents were obtained from
commercial sources and used directly (N,N-dimethylformamide).
Flow reactions were carried out using Vapourtec R2+ [31] and Syrris
Asia[32] pumps and a Polar Bear Plus cooling unit (Cambridge Reac-
tor Design).[33]
Thin layer chromatography (TLC) was carried out using 0.25 mm
thick glass backed Merck TLC Silica gel 60 F254 plates which were
visualised using ultraviolet radiation and aqueous acidic ammoni-
um molybdate (VII) solution or potassium permanganate solution.
Preparatory TLC was carried out using Analtech 20Õ20 cm UNI-
PLATE Silica gel GF (preparative layer with UV254) plates of either
500, 1000 or 2000 microns depth and were visualised using UV.
Flash column chromatography was carried out using high-purity
grade silica gel (Merck grade 9385) with a pore size 60 æ and 230–
400 mesh particle size. Infrared spectroscopy was recorded using
a PerkinElmer Spectrum One FT-IR spectrometer using Universal
ATR sampling accessories. Absorbance measurements were record-
ed in the range 4000–650 cm¢1. NMR spectra were recorded using
either a 400 MHz DPX-400 Dual spectrometer, a 500 MHz AV III HD
Smart Probe spectrometer or a 600 MHz Avance 600 BBI spectrom-
eter as indicated. Unless otherwise stated, all samples were run at
room temperature in deuterated solvent, with chemical shift (d) re-
Table 4. Flow macrocyclisation.
Entry Product R Starting material Solvent Time Yield
# n [%]
1 9a C6H5 8a 2 CH2Cl2 6 h 68
2 1a C6H5 10a 3 CH2Cl2 6 h 76
3 2a C6H5 11a 4 CH2Cl2/MeOH (2 mL/5 mL) 6 h 25 min 80
4 9b CH(CH3)2 8b 2 MeOH 5 h 35 min 86
5 1b CH(CH3)2 10b 3 MeOH 6 h 84
6 2b CH(CH3)2 11b 4 MeOH 6 h 5 min 93
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ported to the nearest 0.01 (1H)/0.1 ppm (13C), relative to the residu-
al protic solvent; d(CDCl3)=7.26 (
1H)/77.16 ppm (13C); d([D8]-tolu-
ene)=2.09, 6.98, 7.00, 7.09 (1H)/20.40, 125.49, 128.33, 129.24,
137.86 ppm (13C) or d([D6]-DMSO) 2.50 (
1H)/39.51 ppm (13C). All
carbon NMRs were run with broadband proton decoupling. Multi-
plicity of a signal in 1H NMR spectra is indicated by: s= singlet, d=
doublet, t= triplet or, q=quartet, quint=quintet, m=multiplet, or
a combination thereof. Multiplets are reported as the range of
ppm values covered by the signals, otherwise the centre of the
signal is given. Coupling constants (J) are quoted in Hz and record-
ed to the nearest 0.1 Hz. HRMS was performed using either
a Waters Micromass LCT Premier spectrometer or by using a Bruker
Bioapex 47e FTICR spectrometer, using positive ESI+ . Masses are
given in m/z units. Melting points (m.p.) were measured using
a Stanford Research Systems OptiMelt automated melting point
system using a gradient of 1 8Cmin¢1, and are uncorrected. Specific
optical rotation was recorded on a Perkin–Elmer Model 343 digital
polarimeter, using a Na/Hal lamp set at 589 nm and with a path-
length of 100 mm. All [aD] values were measured using spectrosco-
py grade solvent at the specified concentration [gcm¢3] and tem-
perature, with units of 10¢1 cm2g¢1. Additional data related to this
publication is available at the University of Cambridge Institutional
Data Repository (https://www.repository.cam.ac.uk/handle/1810/
252536).
Synthesis and characterisation
d-Hiv-OBn (4): Caesium carbonate (4.45 g, 13.7 mmol) was added
to a solution of d-hydroxyisovaleric acid (3 ; 3.22 g, 27.3 mmol) in
N,N-dimethylformamide (20 mL) at 0 8C and the resulting mixture
was stirred for 40 min. Benzyl bromide (3.6 mL, 30.0 mmol) was
added and the reaction mixture was stirred at room temperature
for 15 h. The reaction mixture was filtered and the filtrate was di-
luted with 40–60 petroleum ether/ethyl acetate (4:1, 120 mL). The
organic layer was washed with saturated ammonium chloride solu-
tion (100 mL), saturated sodium bicarbonate (NaHCO3) solution
(100 mL) and saturated sodium chloride (NaCl) solution (100 mL)
before being dried over magnesium sulfate (MgSO4) and the sol-
vent being removed in vacuo. The crude product was purified by
flash column chromatography using 40–60 petroleum ether/ethyl
acetate (10:1) as eluent to afford the title compound 4 (4.56 g,
21.9 mmol, 80%) as a colourless oil. The 1H and 13C data were in
agreement with that reported in the literature.[34] Rf=0.29 [40–60
petroleum ether/diethyl ether=10:1]; [a25:8D ]= +17.8 (c 3.35 EtOH)
literature;[35] [a20D ]= +15.4 (c 2.1, EtOH);
1H NMR (400 MHz,
[D6]DMSO): d=7.49–7.26 (m, 5H, C1’cH–C1’eH), 5.32 (br s. , 1H,
C2OH), 5.25–5.02 (m, 2H, C1’aH2), 3.86 (d, J=5.0 Hz, 1H, C2H),
2.04–1.81 (m, 1H, C3H), 0.87 (d, J=6.9 Hz, 3H, C4H3), 0.81 ppm (d,
J=6.9 Hz, 3H, C4H3) ;
13C NMR (151 MHz, [D6]-DMSO): d=172.5
(quat. , C1), 135.6 (quat. , C1’b), 127.6, 127.5, 127.2 (5ÕCH, C1’c–
C1’e), 74.7 (CH2, C1’a), 64.8 (CH, C2), 31.1 (CH, C3), 17.7 (CH3, C4),
16.3 ppm (CH3, C4).
Boc-Me-Phe-d-Hiv-OBn (6a): EDCI (1.72 g, 9.0 mmol) was added to
a solution of d-Hiv-OBn (4 ; 1.30 g, 6.3 mmol), Boc-N-methyl-l-phe-
nylalanine (5a ; 2.50 g, 8.95 mmol) and 4-DMAP (0.99 g, 8.1 mmol)
in dichloromethane (25 mL) at 0 8C and the resulting mixture was
stirred at room temperature for 14.5 h. The reaction was ended by
the addition of aqueous HCl (25 mL, 1m) and the phases were sep-
arated. The aqueous layer was extracted with dichloromethane (3Õ
30 mL) and the combined organic layers were washed with water
(100 mL), saturated NaHCO3 solution (100 mL) and saturated NaCl
solution (100 mL) before being dried over MgSO4 and the solvent
being removed in vacuo. The crude product was purified by flash
Figure 3. Overall yields for literature,[13, 14] batch and the flow integrated syntheses of the target CODs.
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column chromatography using 40–60 petroleum ether/ethyl ace-
tate (10:1) as eluent to afford the title compound 6a (2.69 g,
5.7 mmol, 92%) as a colourless oil. Rf=0.34 [40–60 petroleum
ether/diethyl ether=10:1]; [a23:7D ]=¢30.9 (c 1.00, CHCl3) ; 1H NMR
(400 MHz, [D6]-DMSO, T=403 K): d=7.47–7.13 (m, 10H, d-Hiv-
C1’cH–d-Hiv-C1’eH and Phe-C5H–Phe-C7H), 5.20 (s, 2H, d-Hiv-
C1’aH2), 4.99 (dd, J=10.4, 5.4 Hz, 1H, Phe-C2H), 4.92 (d, J=4.6 Hz,
1H, d-Hiv-C2H), 3.23 (dd, J=14.6, 5.4 Hz, 1H, Phe-C3H), 3.01 (dd,
J=14.6, 10.4 Hz, 1H, Phe-C3H), 2.70 (s, 3H, Phe-NCH3), 2.28–2.13
(m, 1H, d-Hiv-C3H), 1.33 (s, 9H, Phe-C2’cH3), 0.96 (d, J=6.9 Hz, 3H,
d-Hiv-C4H3), 0.93 ppm (d, J=6.9 Hz, 3H, d-Hiv-C4H3) ;
13C NMR
(101 MHz, [D6]-DMSO, T=403 K): d=169.6 (quat. , Phe-C1), 167.8
(quat. , d-Hiv-C1), 155.5 (quat. , Phe-C2’a), 136.8 (quat. , Phe-C4),
135.0 (quat., d-Hiv-C1’b), 128.0, 127.7, 127.4, 127.3, 125.6 (10ÕCH,
d-Hiv-C1’c–d-Hiv-C1’e, Phe-C5–Phe-C7), 78.7 (quat. , Phe-C2’b), 76.4
(CH, d-Hiv-C2), 65.7 (CH2, d-Hiv-C1’a), 58.8 (CH, Phe-C2), 33.8 (CH2,
Phe-C3), 30.2 (CH3, Phe-NC), 29.1 (CH, d-Hiv-C3), 27.3 (3ÕCH3, Phe-
C2’c), 17.5 (CH3, d-Hiv-C4), 16.2 ppm (CH3, d-Hiv-C4); IR (neat): ~n=
2972, 2933, 2880, 1741, 1694, 1455, 1390, 1366, 1167, 1127, 1029,
750, 697 cm¢1; HRMS (ESI): found 470.2531 [M+H]+ C27H36NO6 re-
quires 470.2543 D=2.4 ppm.
Synthesis of Boc-Me-Phe-d-Hiv-Me-Phe-d-Hiv-OBn (8a) [batch]:
Anhydrous HCl (2.5 mL, 4m in dioxane) was added to a solution of
Boc-Me-Phe-d-Hiv-OBn (6a ; 0.31 g, 0.66 mmol) in dioxane (2.5 mL)
at room temperature and the resulting mixture was stirred for 3 h.
The solvent was removed in vacuo and the residue was taken up
sequentially in ethanol (2Õ5 mL) and methanol (5 mL) with the sol-
vent removed in vacuo after each addition to afford the amine HCl
salt, which was used in the next step without further purification.
Hydrogen gas was bubbled through a solution of Boc-Me-Phe-d-
Hiv-OBn (6a ; 0.31 g, 0.66 mmol) and palladium (70 mg, 10% on
charcoal, 0.07 mmol) in tetrahydrofuran (5 mL) for 3 min at room
temperature before the resulting mixture was stirred under a hy-
drogen atmosphere for 2.5 h. The reaction mixture was filtered
through Celite, eluting with ethyl acetate (20 mL). The solvent was
removed in vacuo from the filtrate to afford the acid which was
used in the next step without further purification.
Ghosez reagent (0.096 mL, 0.72 mmol) was added to a solution of
the crude acid in dichloromethane (2.5 mL) at 0 8C and the result-
ing mixture was stirred for 20 min at this temperature. A solution
of the crude amine HCl salt and N,N-diisopropylethylamine
(0.40 mL, 2.36 mmol) in dichloromethane (2.5 mL) was added and
the reaction mixture was allowed to warm to room temperature
and stirred for 17 h. Aqueous HCl (20 mL, 1m) was added and the
phases were separated. The aqueous layer was extracted with di-
chloromethane (3Õ20 mL) and the combined organic layers were
washed with water (40 mL), saturated NaHCO3 solution (40 mL)
and saturated NaCl solution (40 mL) before drying over MgSO4 and
removing the solvent in vacuo. The crude product was purified by
flash column chromatography using 40–60 petroleum ether/ethyl
acetate (10:1) as eluent to afford the title compound 8a (0.33 g,
0.45 mmol, 68%) as a colourless solid. Rf=0.06 [40–60 petroleum
ether/diethyl ether=10:1]; m.p.=120–122 8C; [a23:7D ]=¢47.4 (c
1.00, CHCl3) ;
1H NMR (400 MHz, [D6]-DMSO, T=403 K): d=7.51–
7.31 (m, 5H, d-HivB-C1’cH–d-HivB-C1’eH), 7.31–7.08 (m, 10H, PheA+
B-C5H–PheA+B-C7H), 5.39 (br s, 1H, PheB-C2H), 5.21 (d, J=1.4 Hz,
2H, d-HivB-C1’aH2), 5.11 (d, J=4.8 Hz, 1H, d-Hiv
A-C2H), 4.99–4.90
(m, 2H, PheA-C2H and d-HivB-C2H), 3.32 (dd, J=14.6, 5.4 Hz, 1H,
PheB-C3HH), 3.21 (dd, J=14.6, 5.2 Hz, 1H, PheA-C3HH), 3.07–2.96
(m, 2H PheA-C3HH and PheB-C3HH), 2.94 (s, 3H, PheB-NCH3), 2.72 (s,
3H, PheA-NCH3), 2.22 (pd, J=6.9, 4.8 Hz, 1H, d-Hiv
B-C3H), 1.81 (br.
s, 1H, d-HivA-C3H), 1.31 (s, 9H, 3ÕPheA-C2’cH3), 0.95 (dd, J=6.9,
4.3 Hz, 6H, 2Õd-HivB-C4H3), 0.78 (d, J=6.8 Hz, 3H, d-Hiv
A-C4H3),
0.71–0.55 ppm (m, 3H, d-HivA-C4H3) ;
13C NMR (101 MHz, [D6]-
DMSO, T=403 K): d=169.3 (quat. , PheA-C1), 169.1 (quat. , PheB-C1),
168.3 (quat. , d-HivA-C1), 167.8 (quat., d-HivB-C1), 154.1 (quat. , PheA-
C2’a), 136.9 (quat. , PheA-C4), 136.4 (quat. , PheB-C4), 135.0 (quat., d-
HivB-C1’b), 128.1, 128.0, 127.7, 127.5, 127.4, 127.4, 125.7, 125.6 (15Õ
CH, PheA+B-C5–PheA+B-C7 and d-HivB-C1’c–d-HivB-C1’e), 78.5 (quat. ,
PheA-C2’b), 76.7 (CH, d-HivB-C2), 74.4 (CH, d-HivA-C2), 65.7 (CH2, d-
HivB-C1’a), 58.7 (CH, PheA-C2), 57.5 (CH, PheB-C2), 33.9 (CH2, Phe
B-
C3), 33.6 (CH2, Phe
A-C3), 31.0 (CH3, Phe
B-NC), 30.0 (CH3, Phe
A-NC),
29.0 (CH, d-HivB-C3), 28.6 (CH, d-HivA-C3), 27.3 (3ÕCH3, Phe
A-C2’c),
17.8 (CH3, d-Hiv
A-C4), 17.4 (CH3, d-Hiv
B-C4), 16.3 (CH3, d-Hiv
B-C4),
15.7 ppm (CH3, d-Hiv
A-C4); IR (neat): ~n=2962, 2937, 1761, 1737,
1683, 1662, 1454, 1394, 1290, 1167, 1128, 1029, 745, 696 cm¢1;
HRMS (ESI): found 731.3878 [M+H]+ C42H55N2O9 requires 731.3907
D=3.9 ppm.
Synthesis of Boc-Me-Phe-d-Hiv-Me-Phe-d-Hiv-OBn (8a) [flow]: Di-
peptidol 6a (0.024 g, 0.05 mmol) was taken up in dichloromethane
and this solution was hydrogenated using an H-CubeÒ Pro (Thales-
Nano) with a 10% Pd/C CatCartÒ. The pump was run at 1 mLmin¢1
using dichloromethane with the temperature set to 60 8C and the
pressure to 6 bar. The solvent was then removed in vacuo and the
crude acid was used directly in the coupling.
Dipeptidol 6a (0.024 g, 0.05 mmol) was taken up in dioxane (1 mL)
and anhydrous HCl (1 mL, 4m in dioxane) was added and the reac-
tion mixture stirred at room temperature for 3 h. The solvent was
then removed in vacuo and the crude oil was taken up in ethanol
(2Õ2 mL) and methanol (2 mL) successively, removing the solvent
in vacuo after each addition to afford the amine as the HCl salt,
which was used directly in the coupling.
The flow equipment was set up according to Table 3. The crude
acid was taken up in dichloromethane (5 mL) and filled into loop 1.
Ghosez reagent (0.013 mL, 0.1 mmol) was taken up in dichlorome-
thane (5 mL) and filled into loop 2. The crude amine HCl salt and
diisopropylethylamine (0.032 mL, 0.18 mmol) were taken up in di-
chloromethane (4.968 mL) and filled into loop 3. Pumps 1–3 were
run a 1 mLmin¢1 with dichloromethane and injection loops 1–3 in-
jected at the appropriate time to ensure coordinated meeting of
streams at the T-pieces (determined by runs using Sudan red dye):
loop 1 at t=0, loop 2 at t=23 s and loop 3 at t=4 min 53 s. From
t=15 min to t=26 min the reaction outflow was collected in stir-
ring aqueous HCl (10 mL, 1m) at 0 8C. The reaction mixture was ex-
tracted with dichloromethane (3Õ20 mL) and the combined organ-
ic extracts were washed with water (10 mL), saturated NaHCO3
(10 mL) and saturated NaCl (10 mL) before being dried over MgSO4
and the solvent being removed in vacuo. The resultant crude prod-
uct was then purified using preparative TLC using 40–60 petrole-
um ether/ethyl acetate (2:1) as eluent to afford the title compound
8a (0.031 g, 0.042 mmol, 82%) as a colourless solid, which was
spectroscopically identical to that reported using method A.
Synthesis of beauvericin (1a) [batch]: Hydrogen gas was bubbled
through a solution of dipeptidol trimer 10a (83 mg, 84 mmol) and
palladium (9 mg, 10% on charcoal, 8.4 mmol) in tetrahydrofuran
(2 mL) for 3 min at room temperature before the mixture was
stirred under hydrogen for 6 h. The reaction mixture was filtered
through Celite and washed with ethyl acetate (30 mL). The solvent
was removed in vacuo from the filtrate to afford the acid, which
was then taken up in dioxane (2 mL). Anhydrous HCl (2 mL, 4m in
dioxane) was added and the resulting mixture was stirred for 6 h.
The solvent was removed in vacuo and the residue was taken up
sequentially in ethanol (2Õ5 mL) and methanol (5 mL) removing
the solvent in vacuo after each addition to afford the deprotected
linear precursor. This was taken up in dichloromethane (20 mL)
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and cooled to 0 8C before Ghosez reagent (12 mL, 92 mmol) was
added at and the resulting mixture was stirred for 30 min at this
temperature. N,N-Diisopropylethylamine (51 mL, 301 mmol) was
added and the reaction mixture was warmed to room temperature
and stirred for 18.5 h. The solvent was removed in vacuo and the
residue was taken up in diethyl ether (60 mL) and aqueous HCl
(60 mL, 1m). The aqueous layer was extracted with diethyl ether
(3Õ30 mL) and the combined organic layers were washed with
water (100 mL), saturated NaHCO3 solution (100 mL) and saturated
NaCl solution (100 mL) before being dried over MgSO4 and the sol-
vent being removed in vacuo. The crude product was purified by
flash column chromatography using 40–60 petroleum ether/ethyl
acetate (2:1!1:1) as eluent to afford the title compound 1a
(46 mg, 59 mmol, 70%) as a colourless solid. The 1H and 13C NMR
spectra were in agreement with that published in the literature.[36]
Rf=0.15 [40–60 petroleum ether/diethyl ether=1:1]; m.p.=92–
93 8C (literature=92–93 8C[36]) ; [a24:7D ]= +75 (c 0.1 MeOH) litera-
ture;[13] [a20D ]= +69 (c 0.1, MeOH);
1H NMR (600 MHz, CDCl3): d=
7.41–7.07 (m, 5H, Phe-C5H–Phe-C7H), 5.46 (dd, J=11.5, 4.9 Hz, 1H,
Phe-C2H), 4.92 (d, J=8.6 Hz, 1H, d-Hiv-C2H), 3.36 (dd, J=14.6,
4.9 Hz, 1H, Phe-C3H), 3.11–2.91 (m, 4H, Phe-C3H and Phe-NCH3),
2.02 (hept. , J=6.7 Hz, 1H, d-Hiv-C3H), 0.80 (d, J=6.7 Hz, 3H, d-
Hiv-C4H3), 0.43 ppm (d, J=6.7 Hz, 3H, d-Hiv-C4H3) ;
13C NMR
(151 MHz, CDCl3): d=170.0 (quat. , Phe-C1), 169.5 (quat. , d-Hiv-C1),
136.8 (quat. , Phe-C4), 129.0, 128.7, 126.9 (5ÕCH, Phe-C5–Phe-C7),
75.6 (CH, d-Hiv-C2), 57.5 (CH, Phe-C2), 34.9 (CH2, Phe-C3), 32.5 (CH3,
Phe-NC), 29.8 (CH, d-Hiv-C3), 18.4, 17.6 ppm (2ÕCH3, d-Hiv-C4); IR
(neat): ~n=2964, 2933, 1743, 1659, 1456, 1411, 1370, 1263, 1178,
1106, 1015, 731, 697 cm¢1; HRMS (ESI): found 784.4183 [M+H]+
C45H58N3O9 requires 784.4173 D=1.3 ppm.
Synthesis of beauvericin (1a) [flow]: Dipeptidol trimer 10a
(0.050 g, 0.05 mmol) was taken up in dichloromethane (5 mL) and
this solution was hydrogenated using an H-CubeÒ Pro (ThalesNa-
no) with a 10% Pd/C CatCartÒ. The pump was run at 1 mLmin¢1
using dichloromethane with the temperature set to 60 8C and the
pressure to 6 bar. The solvent was then removed in vacuo and the
crude acid was taken up in dioxane (1 mL). Anhydrous HCl (1 mL,
4m in dioxane) was added and the reaction mixture was stirred at
room temperature for 6 h. The solvent was then removed in vacuo
and the crude oil taken up in ethanol (2Õ2 mL) and methanol
(2 mL) successively, removing the solvent in vacuo after each addi-
tion to afford the crude cyclisation precursor.
The flow equipment was set up according to Table 4. The cyclisa-
tion precursor was taken up in dichloromethane (5 mL) and filled
into loop 1. Ghosez reagent (0.013 mL, 0.1 mmol) was taken up in
dichloromethane (5 mL) and filled into loop 2. Pumps 1 and 2 were
run at 1 mLmin¢1 with dichloromethane and pump 3 at 1 mLmin¢1
with a solution of diisopropylethylamine (0.036m) in dichlorometh-
ane. Injection loops 1 and 2 were injected at the appropriate time
to ensure coordinated meeting of streams at the T-pieces (deter-
mined by runs using Sudan red dye): loop 1 at t=0, loop 2 at t=
23 s. From t=15 min to t=26 min the reaction outflow was col-
lected in stirring aqueous HCl (20 mL, 1m) at 0 8C. The reaction
mixture was extracted with dichloromethane (3Õ20 mL) and the
combined organic extracts were washed with water (10 mL), satu-
rated NaHCO3 (10 mL) and saturated NaCl (10 mL) and were dried
over MgSO4 and the solvent removed in vacuo. The crude product
was purified using preparative TLC using toluene/ethyl acetate
(2:1) as eluent to afford the title compound 1a (0.030 g,
0.038 mmol, 76%) as a colourless solid, which was spectroscopical-
ly identical to that reported using method A.
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